OptimizeRx Corporation (OPRX) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

OptimizeRx Corporation (OPRX) Healthcare & Pipeline Overview

OptimizeRx Corporation operates as a digital health technology company, delivering solutions that streamline communication between pharmaceutical manufacturers, healthcare providers, and patients. Their focus on financial messaging, patient support, and brand awareness positions them within the evolving healthcare information services sector, leveraging technology to improve patient outcomes and medication adherence.

What Is the Investment Thesis for OPRX?

OptimizeRx Corporation operates in the growing digital health market, connecting pharmaceutical companies with healthcare providers and patients. With a market capitalization of $135M and a P/E ratio of 29.47, the company demonstrates profitability with a 4.7% profit margin and a strong 63.3% gross margin. Key value drivers include the increasing adoption of digital health solutions by pharmaceutical companies and healthcare providers, as well as the growing need for improved medication adherence and patient engagement. Growth catalysts include expanding the reach of their Mobile Health Messenger platform and leveraging their data analytics capabilities to provide more targeted and personalized patient support. Potential risks include increasing competition in the digital health space and regulatory changes affecting the pharmaceutical industry. The company's beta of 1.28 suggests higher volatility compared to the market.

Based on FMP financials and quantitative analysis

OPRX Key Highlights

Market capitalization of $135M indicates the company's current valuation in the market.

• P/E ratio of 29.47 suggests investors are willing to pay $23.42 for every dollar of earnings.
• Profit margin of 4.7% demonstrates the company's ability to generate profit from its revenue.
• Gross margin of 63.3% indicates the company's efficiency in managing production costs.
• Beta of 1.28 suggests the stock is more volatile than the market.

Who Are OPRX's Competitors?

OPRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are OPRX's Key Strengths?

Established presence in the digital health technology space.

• Strong relationships with pharmaceutical manufacturers and healthcare providers.
• Proprietary technology platform for delivering digital health solutions.
• HIPAA-compliant data security and privacy practices.

What Are OPRX's Weaknesses?

Relatively small market capitalization compared to larger competitors.

• Dependence on the pharmaceutical industry for revenue.
• Limited geographic reach outside of the United States.
• Potential for regulatory changes affecting the pharmaceutical industry.

What Could Drive OPRX Stock Higher?

Expansion of the Mobile Health Messenger platform to new therapeutic areas.

• Potential partnerships with healthcare providers to integrate OptimizeRx's solutions into EHR systems.
• Increased adoption of digital health technologies by pharmaceutical companies and healthcare providers.
• Development and launch of new patient engagement solutions.
• Leveraging data analytics capabilities to provide more targeted and personalized patient support.

What Are the Key Risks for OPRX?

Rich valuation — a P/E of 29.47 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.

• Increasing competition in the digital health technology space.
• Potential for data breaches and security vulnerabilities.
• Changes in healthcare regulations and reimbursement policies.
• Dependence on the pharmaceutical industry for revenue.
• Economic downturn affecting the pharmaceutical industry.

What Are the Growth Opportunities for OPRX?

• Expansion into new therapeutic areas: OptimizeRx can expand its reach by targeting new therapeutic areas and developing specialized solutions for specific patient populations. The market for digital health solutions in chronic diseases, such as diabetes and cardiovascular disease, is particularly large and growing. By developing tailored programs and messaging for these areas, OptimizeRx can attract new pharmaceutical clients and increase its revenue. This expansion can be achieved within the next 1-2 years, leveraging the existing platform and infrastructure.
• Geographic expansion: OptimizeRx can expand its geographic reach by targeting new markets outside of the United States. The demand for digital health solutions is growing globally, particularly in countries with aging populations and increasing healthcare costs. By partnering with local healthcare providers and pharmaceutical companies, OptimizeRx can establish a presence in these markets and tap into new revenue streams. This expansion could begin within the next 2-3 years, starting with pilot programs in select countries.
• Enhanced data analytics capabilities: OptimizeRx can enhance its data analytics capabilities to provide more targeted and personalized patient support. By leveraging data on patient demographics, medication history, and adherence patterns, the company can develop customized messaging and interventions that are more likely to improve patient outcomes. This requires investment in data science and analytics infrastructure, but the potential return on investment is significant. The development and implementation of these enhanced capabilities can be achieved within the next 1-2 years.
• Partnerships with healthcare providers: OptimizeRx can strengthen its relationships with healthcare providers by offering them new tools and resources to improve patient care. This could include integrating its platform with electronic health record (EHR) systems, providing access to clinical decision support tools, and offering training and education programs for healthcare professionals. By becoming a trusted partner to healthcare providers, OptimizeRx can increase its market share and improve its brand reputation. These partnerships can be developed and expanded over the next 1-3 years.
• Development of new patient engagement solutions: OptimizeRx can develop new patient engagement solutions that go beyond medication adherence and address other aspects of patient health and well-being. This could include developing mobile apps for tracking symptoms, providing access to telehealth services, and offering personalized health coaching. By expanding its offerings to address a broader range of patient needs, OptimizeRx can attract new customers and increase its revenue. The development and launch of these new solutions can be phased in over the next 2-4 years.

What Are OPRX's Competitive Advantages?

• Established relationships with pharmaceutical manufacturers and healthcare providers.
• Proprietary technology platform for delivering digital health solutions.
• HIPAA-compliant data security and privacy practices.
• Integration with electronic medical record (EMR) and e-prescribing (eRx) systems.

What Does OPRX Do?

Founded in 2006, OptimizeRx Corporation has evolved into a key player in the digital health technology space. The company provides a suite of solutions designed to connect life sciences organizations, healthcare providers, and patients, aiming to improve medication adherence, streamline communication, and enhance patient outcomes. OptimizeRx's initial focus was on leveraging electronic prescribing (eRx) systems to deliver financial messaging and patient support directly to physicians. This evolved into a broader platform offering brand awareness messaging, therapeutic support, and patient engagement tools. Their product suite includes a virtual patient support center, enabling access to sample vouchers, co-pay coupons, and other patient support resources through EMR and e-prescribe systems. They also offer brand support services, assisting pharmaceutical manufacturers in developing and implementing eRx media strategies. OptimizeRx operates a cloud-based Mobile Health Messenger platform, facilitating interactive health messaging for medication adherence and care coordination. Their HIPAA-compliant automated mobile messaging platform allows direct patient engagement, enhancing regimen compliance. The company also provides patient programs with treatment information, lifestyle trackers, and internet device connectivity. Headquartered in Rochester, Michigan, OptimizeRx continues to expand its offerings and market reach within the healthcare industry.

What Products and Services Does OPRX Offer?

• Connects life sciences organizations with healthcare providers and patients.
• Provides financial messaging services to deliver sample vouchers and co-pay coupons.
• Offers brand awareness and therapeutic support messaging services.
• Operates a cloud-based Mobile Health Messenger platform for medication adherence.
• Provides HIPAA-compliant automated mobile messaging for patient engagement.
• Offers patient programs with treatment and affordability information.
• Provides evidence-based physician engagement solutions using real-world data.
• Offers therapy initiation workflow focused on accelerating patient access to treatments.

How Does OPRX Make Money?

• Generates revenue by providing digital communication and engagement solutions to pharmaceutical manufacturers.
• Charges fees for delivering financial messaging and patient support services through EMR and e-prescribe systems.
• Earns revenue from brand awareness and therapeutic support messaging services.
• Offers subscription-based access to its Mobile Health Messenger platform.

What Industry Does OPRX Operate In?

OptimizeRx operates within the healthcare information services industry, which is experiencing significant growth due to the increasing adoption of digital health technologies and the growing need for improved patient engagement and medication adherence. The market is competitive, with companies offering various solutions for connecting pharmaceutical companies, healthcare providers, and patients. OptimizeRx differentiates itself through its focus on financial messaging, patient support, and brand awareness within the eRx ecosystem. The industry is expected to continue growing as healthcare providers and pharmaceutical companies seek to improve patient outcomes and reduce costs through digital solutions.

Who Are OPRX's Key Customers?

• Pharmaceutical manufacturers seeking to promote their products and improve patient adherence.
• Healthcare providers looking to access patient support resources and improve patient outcomes.
• Patients seeking information and support for their medications and health conditions.

Over the past six months, OptimizeRx Corporation insiders filed 20 SEC Form 4 transactions — 9 sales and 11 purchases. On net that is roughly 440K shares acquired (about $101K) — insiders putting money in tends to read as conviction.

Quarterly Financial Performance: OptimizeRx Corporation

Revenue for OptimizeRx Corporation came in at $20.5M during Q2 FY2026, a 3.3% improvement versus the preceding quarter. The company recorded a net loss of $703K, with diluted EPS of $-0.04. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, OPRX averaged $0.06 in diluted EPS.

OPRX Valuation & Market Position

With a $135M market cap, OptimizeRx Corporation sits in the micro-cap segment of the market. Analyst price targets span from $7.00 to $12.00, with a consensus of $10.25. At the current price of $7.18, that implies approximately 43% upside potential. Relative to its peer group, OPRX's quantitative score of 87/100 is above the peer average of 62/100.

Return on equity for OptimizeRx Corporation stands at 5.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.1%, showing how much profit it generates from its asset base. OPRX trades at a trailing price-to-earnings ratio of 29.47, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 12.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 5.37 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.1%, the inverse of the P/E and a quick read on earnings relative to price.

OptimizeRx Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.90 places it in the grey zone, a middle ground that warrants monitoring.

OptimizeRx Corporation has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 378.1% above estimates on average.

Company Profile

OptimizeRx Corporation operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Waltham, US. The company is led by CEO Stephen L. Silvestro. OPRX has traded publicly since 2007.

OPRX Financials

OPRX Latest News

OPRX Analyst Consensus

OPRX MoonshotScore

OptimizeRx Corporation Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources